USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	050024/0722			Pages:	42
		Recorded:	08/12/2019
Attorney Dkt #:	FNJ-000
Conveyance:	ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).

Total properties: 11

Patent #:	7846440	Issue Dt:	12/07/2010	Application #:	12281925	Filing Dt:	09/05/2008
Publication #:	US20090291085	Pub Dt:	11/26/2009
Title:	ANTIBODIES AGAINST ERBB3 AND USES THEREOF

Patent #:	NONE	Issue Dt:	12/07/2010	Application #:	12281925	Filing Dt:	09/05/2008
Publication #:	US20090291085	Pub Dt:	11/26/2009			PCT #:	US2008002119
Title:	ANTIBODIES AGAINST ERBB3 AND USES THEREOF

Patent #:	8691225	Issue Dt:	04/08/2014	Application #:	12545279	Filing Dt:	08/21/2009
Publication #:	US20100266584	Pub Dt:	10/21/2010
Title:	ANTIBODIES AGAINST THE ECTODOMAIN OF ERBB3 AND USES THEREOF

Patent #:	8961966	Issue Dt:	02/24/2015	Application #:	12904492	Filing Dt:	10/14/2010
Publication #:	US20110123523	Pub Dt:	05/26/2011
Title:	ANTIBODIES AGAINST ERBB3 AND USES THEREOF

Patent #:	8895001	Issue Dt:	11/25/2014	Application #:	13583949	Filing Dt:	09/11/2012
Publication #:	US20130034548	Pub Dt:	02/07/2013
Title:	USE OF ERBB3 INHIBITORS IN THE TREATMENT OF TRIPLE NEGATIVE AND BASAL-LIKE BREAST CANCERS

Patent #:	NONE	Issue Dt:	11/25/2014	Application #:	13583949	Filing Dt:	09/11/2012
Publication #:	US20130034548	Pub Dt:	02/07/2013			PCT #:	US2011028129
Title:	USE OF ERBB3 INHIBITORS IN THE TREATMENT OF TRIPLE NEGATIVE AND BASAL-LIKE BREAST CANCERS

Patent #:	9345766	Issue Dt:	05/24/2016	Application #:	14015776	Filing Dt:	08/30/2013
Publication #:	US20140079703	Pub Dt:	03/20/2014
Title:	COMBINATION THERAPIES COMPRISING ANTI-ERBB3 AGENTS

Patent #:	9487588	Issue Dt:	11/08/2016	Application #:	14181334	Filing Dt:	02/14/2014
Publication #:	US20140234329	Pub Dt:	08/21/2014
Title:	ANTIBODIES AGAINST THE ECTODOMAIN OF ERBB3 AND USES THEREOF

Patent #:	9518130	Issue Dt:	12/13/2016	Application #:	14518900	Filing Dt:	10/20/2014
Publication #:	US20150132292	Pub Dt:	05/14/2015
Title:	USE OF ERBB3 INHIBITORS IN THE TREATMENT OF TRIPLE NEGATIVE AND BASAL-LIKE BREAST CANCERS

Patent #:	NONE	Issue Dt:		Application #:	15994393	Filing Dt:	05/31/2018
Publication #:	US20190119401	Pub Dt:	04/25/2019
Title:	USE OF ERBB3 INHIBITORS IN THE TREATMENT OF TRIPLE NEGATIVE AND BASAL-LIKE BREAST CANCERS

Patent #:	NONE	Issue Dt:		Application #:	16181054	Filing Dt:	11/05/2018
Publication #:	US20190292271	Pub Dt:	09/26/2019
Title:	ANTIBODIES AGAINST THE ECTODOMAIN OF ERBB3 AND USES THEREOF

Assignor

Exec Dt:

07/12/2019

Assignee

888 7TH AVE. #30

NEW YORK, NEW YORK 10106

Correspondence name and address
	NELSON MULLINS RILEY & SCARBOROUGH LLP
	ONE POST OFFICE SQUARE
	30TH FLOOR
	BOSTON, MA 02109-2127

Search Results as of: 05/31/2024 07:08 PM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6